Polycystic ovarian syndrome Nutritional, Metabolic, Endocrine Polycystic ovarian syndrome
Conditions
Interventions
Treatment group (EA Group): The patient receives adjuvant electroacupuncture. Sites used are the Zhongji (CV3), Guanyuan (CV4), Qihai (CV6), Tianshu (ST25), Shuidao (ST28), Zusanli (ST36), Chengsan (B
Sponsors
University of Indonesia and Cipto Mangunkusumo Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. 18 - 40 years old 2. BMI > 23kg/m² 3. Volunteering to join this research and giving informed consent
Exclusion criteria
Exclusion criteria: 1. Suffering from malignancy 2. Suffering from hypertension (blood pressure >140/90 mmHg, JNC 7 criteria) 3. Suffering from diabetes mellitus (fasting blood sugar >126 mg/dL, PERKENI 2015 criteria) 4. Currently in lactation 5. Suffering from endocrine disorders associated with steroid sex hormones such as congenital adrenal hyperplasia, Cushing’s syndrome, and androgen-secreting tumor diagnosed by a gynecologist 6. Currently undergoing pharmacological therapy related to dominant follicles stimulation such as clomiphene citrate, letrozole, FSH within 3 months 7. Subjects undergoing acupuncture therapy in the 12 weeks prior to recruitment 8. Subjects with absolute contraindications to electroacupuncture therapy such as: the first trimester of pregnancy, patients in a state of shock or coma, body temperature >38 degrees C, septicemia, tuberculosis of the skin or other local skin infection, heart rhythm disorders and patients with pacemakers, hypertension 9. Subjects with relative contraindications to electroacupuncture therapy such as: a history of epilepsy, pain and acute edema, and in patients with metal implants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Menstrual cycle length is measured in days using interview at baseline (before 1st session) and the end of acupuncture sessions (after 12th session) 2. Ovarian volume is measured in ml using transvaginal ultrasonography at baseline (before 1st session) and the end of acupuncture sessions (after 12th session) 3. Number of antral follicles is measured using transvaginal ultrasonography at baseline (before 1st session) and the end of acupuncture sessions (after 12th session) | — |
Secondary
| Measure | Time frame |
|---|---|
| Menstruation occurrence is measured using interview at baseline (before 1st session) and the end of acupuncture sessions (after 12th session) | — |
Countries
Indonesia
Contacts
Public ContactWenny Kurniawan
Outcome results
None listed